Extensive hepatic necrosis after transarterial chemoembolization.
Department Internal Medicine, Akron General Medical Center, 400 Wabash Avenue, Akron, OH, 44307, USA, mdagito@yahoo.com.
Markus D
MD
Agito
Reynaldo
R
Gacad
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging / Q000473:pathology* / Q000556:secondary / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects* / Q000379:methods; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006499:Hepatic Artery; D006801:Humans; D008099:Liver / Q000473:pathology*; D017093:Liver Failure / Q000209:etiology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009102:Multiple Organ Failure / Q000209:etiology; D009336:Necrosis; D018805:Sepsis / Q000000981:diagnostic imaging / Q000209:etiology; D014057:Tomography, X-Ray Computed
D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin